When the need arose for a revolutionary hand sanitiser to be developed during the coronavirus outbreak of 2020, Akkedis UK Ltd realised they had the key ingredient to make a sanitizer more superior than all the rest. Its licence for Carbohydrate Derived Fulvic Acid (CHD-FA™) (owned by Fulhold Pharma Ltd UK) meant that they were able to produce an effective hand sanitiser without the use of alcohol but instead with Carbohydrate Derived Fulvic Acid (CHD-FA™).
CHD-FA™ is a patented supra-molecular technology platform. The molecule has powerful, broad-based anti-bacterial, anti-fungal, anti-viral and anti-inflammatory properties, in topical applications, making it an effective ingredient in the fight against infection, including Coronavirus.
The chemistry of CHD-FA is extensively understood due to the numerous clinical trials conducted by Fulhold, over the past 15 years testing its efficacy against viruses including Influenza and SARS.
Based on the understanding of how effective CHD-FA is against SARS, FulviSafe Hand Sanitizer was created. A non-alcohol based sanitiser containing CHD-FA making it a clinically proven antibacterial and antiviral sanitiser that is kinder to skin than any other.
With the knowledge that overuse of alcohol-based sanitisers damages skin, FulviSafe went on to develop a barrier cream to deeply moisturise skin. It also contains CHD-FA so that it has the added benefit of providing antibacterial and antiviral properties to skin with every use.
FulviSafe was developed to fulfil a need – to produce a range of hand sanitising products that are kind to hands; suitable for the whole family, including babies under 1 year old and those with sensitive skin; alcohol-free; provides long lasting protection proven and to act as an effective barrier against viruses and bacteria.
All FulviSafe products are produced in a South African Health Products Regulatory Authority cGMP (License Nr 0000001280) and Manufacturing Pharmacy (License Nr Y54509), as well as FSSC 22000, approved facility.